Evaluating Primary Endpoints for COVID-19 Therapeutic Trials to Assess Recovery. (2022)

First Author: Douin DJ
Attributed to:  Respiratory infections funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1164/rccm.202112-2836oc

PubMed Identifier: 35580040

Publication URI: http://europepmc.org/abstract/MED/35580040

Type: Journal Article/Review

Volume: 206

Parent Publication: American journal of respiratory and critical care medicine

Issue: 6

ISSN: 1073-449X